With a unique legacy in dermatology as well as decades of cutting-edge innovation, Galderma is the leading company solely dedicated to skin and advancing the future of dermatology.
We deliver an innovative, science-based portfolio of sophisticated brands and services across Aesthetics, Consumer Care and Prescription Medicine.
Through trusted partnerships with healthcare professionals, we ensure to meet individual consumer and patient needs with superior outcomes.
KEY FACTS ABOUT GALDERMA
~3B USD
audited 2020 net sales
~4,600
employees in 100 countries
4
manufacturing sites
1,200+
employees work at our 4 manufacturing sites. We make 75% of our products in house.
3
Global Business Units: Aesthetics, Consumer Care and Prescription Medicine
World presence
we operate from 50 sites in 40 countries, with our headquarters in Switzerland.
A timeline of our history
1981
Foundation of Galderma as a joint venture between L’Oréal and Nestlé
Following the invention of the first Cetaphil formulation in 1947
1984
Galderma discovers Adapalene
1986
First commercial operations
1995
Launch of Differin for acne treatment
2000
Opening of our production site in Baie d’Urfé, Canada
2001
Licensing agreement for Metvix (Skin cancer)
2004
Opening of our production site in Hortolândia, Brazil
2007
Launch of Differin 0.3%
2008
Launch of Epiduo
2009
Launch of Azzalure and Restylane Injector
